Hereditary Cancer in Clinical Practice (Jul 2021)

Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature

  • Leandro Jonata Carvalho Oliveira,
  • Aline Bobato Lara Gongora,
  • Fabiola Ambrosio Silveira Lima,
  • Felipe Sales Nogueira Amorim Canedo,
  • Carla Vanessa Quirino,
  • Janina Pontes Pisani,
  • Maria Isabel Achatz,
  • Benedito Mauro Rossi

DOI
https://doi.org/10.1186/s13053-021-00189-8
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background The microphthalmia-associated transcription factor gene (MITF) belongs to the MYC supergene family and plays an important role in melanocytes’ homeostasis. Individuals harboring MITF germline pathogenic variants are at increased risk of developing cancer, most notably melanoma and renal cell carcinoma. Case presentation We describe a cohort of ten individuals who harbor the same MITF c.952G > A (p.Glu 318Lys), or p.E318K, germline pathogenic variant. Six carriers developed at least one malignancy (4 cases of breast cancer; 1 cervical cancer; 1 colon cancer; 1 melanoma; 1 ovarian/fallopian tube cancer). A significant phenotypic heterogeneity was found among these individuals and their relatives. Breast cancer was, overall, the most frequent malignancy observed in this case series, with 13 occurrences of 60 (21.67 %) total cancer cases described among the probands and their relatives. Conclusions Our retrospective analysis data raise the hypothesis of a possible association of the MITF p.E318K pathogenic variant with an increased risk of breast cancer.

Keywords